Boeing, J&J, dismal China data drag Wall Street lower

UPS (UPS) Announces Retirement of COO Jim Barber

UPS (NYSE: UPS) today announced Jim Barber, 59, UPS Chief Operating Officer will retire at the end of December 2019. As UPS COO, Barber is responsible for the companys global small package, freight, supply chain and freight forwarding units and global engineering. Serving UPS for nearly 35 years, he joined the company as... More

Actelion Pharmaceuticals Reports New OPSUMIT (macitentan) Data Show Initial Combination Therapy with Tadalafil Improved Hemodynamic Clinical & Functional Parameters in Patients with PAH

Actelion Pharmaceuticals Ltd, a Janssen Pharmaceutical Company of Johnson & Johnson (NYSE: JNJ), today announces new data evaluating initial combination therapy with OPSUMIT® (macitentan) and tadalafIl, a PDE5 inhibitor. Patients with pulmonary arterial hypertension (PAH, WHO Group 1) taking this combination showed hemodynamic improvement, as well as improvements in functional parameters and risk profiles. The combination was also well tolerated in these patients. The study data is being shared today at the CHEST Annual Meeting 2019, held October 19-23 in New Orleans, Louisiana.

The OPTIMA (cOmbination theraPy of maciTentan and tadalafIl in patients with... More

Stifel Reiterates Buy Rating on Amazon.com (AMZN) Ahead of 3Q Report

Stifel analyst Scott Devitt reiterated a Buy rating and $2,300.00 price target on Amazon.com (NASDAQ: AMZN) ahead of the company's 3Q report. Stifel's revenue estimate is modestly ahead of consensus while operating income estimate is below consensus expectations. Amazon is scheduled to report 3Q:19... More

Wells Fargo Reiterates Outperform Rating on American Express (AXP) Following 3Q Report

Wells Fargo analyst Donald Fandetti reiterated an Outperform rating and $140.00 price target on American Express (NYSE: AXP) following the company's 3Q report. AXP reported EPS of $2.08, higher than the consensus of $2.03. Revenues of $10.989B were higher than $10.943B estimates as NII and other... More